| NCT05201638 | Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis | RECRUITING | PHASE3 | 2022-01-12 | 2032-10 | 2024-10 |
| NCT05124795 | IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer | TERMINATED | PHASE1 | 2021-12-09 | 2023-05-31 | 2023-05-31 |
| NCT05134441 | Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis | RECRUITING | PHASE3 | 2021-11-18 | 2032-09 | 2024-09 |
| NCT05054140 | Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-09-30 | 2025-01-07 | 2025-01-07 |
| NCT04379271 | A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) | COMPLETED | PHASE2, PHASE3 | 2020-06-11 | 2021-02-23 | 2021-01-12 |
| NCT03846219 | MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS) | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-01-28 | 2029-12 | 2020-04-24 |
| NCT03341962 | Phase 2 Dose-finding IMU-838 for Ulcerative Colitis | TERMINATED | PHASE2 | 2018-03-15 | 2022-11-16 | 2022-11-16 |